1. Membrane Transporter/Ion Channel
    Neuronal Signaling
  2. iGluR

PEAQX tetrasodium hydrate (Synonyms: NVP-AAM077 tetrasodium hydrate)

Cat. No.: HY-12294A Purity: 98.22%
Handling Instructions

PEAQX(NVP-AAM 077) is a potent and orally active NMDA antagonist with a 15-fold preference for human NMDA receptors with the 1A/2A(IC50=270 nM), rather than 1A/2B(29,600 nM).

For research use only. We do not sell to patients.

PEAQX tetrasodium hydrate Chemical Structure

PEAQX tetrasodium hydrate Chemical Structure

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in Water USD 177 In-stock
Stock in the United States
Estimated Time of Arrival: December 31
5 mg USD 144 In-stock
Stock in the United States
Estimated Time of Arrival: December 31
10 mg USD 240 In-stock
Stock in the United States
Estimated Time of Arrival: December 31
50 mg USD 768 In-stock
Stock in the United States
Estimated Time of Arrival: December 31
100 mg   Get quote  
200 mg   Get quote  

* Please select Quantity before adding items.

Other Forms of PEAQX tetrasodium hydrate:

  • Biological Activity

  • Technical Information

  • Purity & Documentation

  • References

Description

PEAQX(NVP-AAM 077) is a potent and orally active NMDA antagonist with a 15-fold preference for human NMDA receptors with the 1A/2A(IC50=270 nM), rather than 1A/2B(29,600 nM). IC50 value: 270 nM(hNMDA A1/A2) [1] Target: NR2A antagonist in vitro: PEAQX has a high binding affinity for NMDA receptors (IC50=8 nM), and a functional preference in excess of 100-fold for hNMDA 1A/2A (IC50=of 270 nM) over 1A/2B receptors (IC50=29,600 nM) [1]. in vivo: PEAQX is practically inactive in Xenopus oocytes expressing hNMDA 1A/2B receptors, displays an ED50 value of 23 mg/kg in the MES test [1]. Sprague-Dawley rats were treated on PN7, PN9, and PN11 with PCP (10 mg/kg), PEAQX (NR2A-preferring antagonist; 10, 20, or 40 mg/kg), or ifenprodil (selective NR2B antagonist; 1, 5, or 10 mg/kg) and sacrificed for measurement of caspase-3 activity (an index of apoptosis) or allowed to age and tested for locomotor sensitization to PCP challenge on PN28-PN35. PCP or PEAQX on PN7, PN9, and PN11 markedly elevated caspase-3 activity in the cortex; ifenprodil showed no effect. Striatal apoptosis was evident only after subchronic treatment with a high dose of PEAQX (20 mg/kg). Animals treated with PCP or PEAQX on PN7, PN9, and PN11 showed a sensitized locomotor response to PCP challenge on PN28-PN35 [2].

Solvent & Solubility
In Vitro: 

H2O : 25.5 mg/mL (45.52 mM; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.7852 mL 8.9262 mL 17.8524 mL
5 mM 0.3570 mL 1.7852 mL 3.5705 mL
10 mM 0.1785 mL 0.8926 mL 1.7852 mL
*Please refer to the solubility information to select the appropriate solvent.
References
Molecular Weight

560.15

Formula

C₁₇H₁₅BrN₃Na₄O₆P

SMILES

[O-]P([O-])(C(N[[email protected]@H](C)C1=CC=C(Br)C=C1)C2=CC=CC3=C2N=C([O-])C([O-])=N3)=O.[H]O[H].[Na+].[Na+].[Na+].[Na+]

Storage
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
Shipping

Room temperature in continental US; may vary elsewhere

Purity: 98.22%

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
PEAQX tetrasodium hydrate
Cat. No.:
HY-12294A
Quantity:

PEAQX tetrasodium hydrate

Cat. No.: HY-12294A